Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 16, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the registrant.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of shareholding changes rather than a financial performance report.
Material Changes
The filing details a change in the number of Ordinary Share ADRs held by the GlaxoSmithKline US Retirement Savings Plan ("the Plan").
- Date of Movement: March 15, 2007
- Previous Holding: 16,408,516 ADRs
- New Holding: 16,411,831 ADRs
- Average Price: $55.59
- Reason: A movement in the fund.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It notes that the Plan is a discretionary fund for employees and former employees. Two directors, Dr. J P Garnier and Dr. M M Slaoui, are potentially interested in the shares held in the fund in the same manner as other employees. The transaction was notified in accordance with Disclosure Rule 3.1.4R(1)(b).
Investor Verification Points
- Verify the total number of ADRs held by the US Retirement Savings Plan as of March 15, 2007 (16,411,831).
- Confirm the average transaction price of $55.59 for the fund movement.
- Note the potential interest of Directors Dr. J P Garnier and Dr. M M Slaoui in the fund's holdings.